Related Experiment Video

Updated: Aug 17, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[Coronary intervention in 1148 patients with chronic total coronary occlusion]

Ya-ling Han1, Jian Zhang, Quan-min Jing

  • 1Department of Cardiology, Shenyang General Hospital, Cardiovascular Research Institute of PLA, Shenyang 110016, China. hanyal@mail.sy.ln.cn

Zhonghua Xin Xue Guan Bing Za Zhi
|June 4, 2005
PubMed

Insights

Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) lesions achieved high success rates (90.2%) and favorable outcomes in experienced centers. Factors like occlusion time and lesion length influenced success, with low major adverse cardiac events.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Vascular Medicine

Context:

  • Chronic total occlusion (CTO) represents a significant challenge in percutaneous coronary intervention (PCI).
  • Successful revascularization of CTO lesions can improve myocardial perfusion and patient outcomes.
  • Limited data exists on the long-term outcomes and technical success rates of CTO PCI in large patient cohorts.

Purpose:

  • To evaluate the technical success and clinical outcomes of PCI for patients with CTO lesions.
  • To identify factors affecting PCI success in CTO lesions.
  • To assess the safety and efficacy of CTO PCI procedures.

Summary:

  • A retrospective analysis of 1148 patients with 1494 CTO lesions treated with PCI between 1993-2004.
  • Overall success rates were 90.2% for patients and 88.2% for lesions.
  • Success was lower for longer occlusions, stump issues, bridging collaterals, and lesions >= 15mm. In-hospital major adverse cardiac events were 0.6%.

Impact:

  • Demonstrates that high success rates and favorable clinical outcomes are achievable with PCI for CTO lesions in experienced centers.
  • Provides insights into factors influencing CTO PCI success, aiding procedural planning.
  • Contributes to the understanding of the safety profile of CTO PCI, with low rates of major adverse cardiac events.
Abstract

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...